← FDA DRUG APPROVALS

FDA ANDA · ANDA208763

TRIAMCINOLONE ACETONIDE

Sponsor: CHARTWELL RX

APPLICATION
ANDA208763
TYPE
ANDA
ORIGINAL APPROVAL
2017-02-01
LATEST ACTION
2017-02-01
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

TRIAMCINOLONE ACETONIDEPrescription
TRIAMCINOLONE ACETONIDE 0.1% · CREAM · TOPICAL
TRIAMCINOLONE ACETONIDEPrescription
TRIAMCINOLONE ACETONIDE 0.5% · CREAM · TOPICAL
TRIAMCINOLONE ACETONIDEPrescription
TRIAMCINOLONE ACETONIDE 0.025% · CREAM · TOPICAL

Approval history

2017-02-01UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →